Microbiologics, the foremost provider of biomaterials and contract microbiology research services, is pleased to announce the acquisition of Cryologics, a leader in cryopreservation of environmental isolates for use as quality control microorganisms. The procurement of Cryologics extends Microbiologics’ capacity to serve QC microbiologists dedicated to the safety of pharmaceutical and personal care products.
Bob Westney, Founder of Cryologics, said “During my nearly 35 years of experience in the pharmaceutical and biotechnology industries, I have watched and admired Microbiologics’ ingenuity and growth. Its exemplary industry reputation is well-deserved. Microbiologics is truly an outstanding company. That is why I am extremely gratified to pass along Cryologics’ business to Microbiologics, who will no doubt be effective stewards of our customers.”
Noting that Westney has provided decades of leadership in pharmaceutical quality control, CEO of Microbiologics, Brad Goskowicz, stated “We are excited to be combining our expertise with that of an industry veteran in Bob Westney. Bob has over 30 years of industry experience, including extensive knowledge and processes that follow good manufacturing practice (GMP) in Quality Control Microbiology, Quality Assurance, and Regulatory Affairs. We are excited to continue growing to meet the needs of the microbiologists who ensure the safety of critical pharmaceutical and personal care products.”Learn more about Microbiologics custom environmental isolate controls at microbiologics.com.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!